In the News

22 Feb 2012 | Reuters

Lionel Melka comments the Glencore - Xstrata deal

Chinese, Texan and classic on hedge fund menu

"I anticipate a long battle similar to Sanofi/Genzyme (in 2011), with Roche playing shareholder exhaustion and bumping its offer at the 11th hour. I hardly see them closing a deal before summer 2012,” said Lionel Melka...

22 Feb 2012 | Wall Street Journal

Amit Shabi comments the current environment

Hedge Funds Re-Enter Market As M&A Activity Picks Up

"We are seeing more M&A deals in Europe, thus creating more investment opportunities," said Amit Shabi...

08 Feb 2012 | Reuters

Amit Shabi on the Glencore/Xstrata deal

Hedge funds get creative in Glencore-Xstrata deal

Meanwhile, Amit Shabi, partner at Paris-based Bernheim, Dreyfus & Co, told Reuters the current deal spread of 5 percent annualised was "not worth looking at"...

02 Feb 2012 | Reuters

Lionel Melka comments the current regulatory environement

Rising regulatory risk squashing M&A deals, say advisers

“Companies must anticipate antitrust issues as soon as when the deal is in gestation. The smartest ones would try to sound the regulator even before deciding whether to launch a bid to see if the antitrust is manageable,...”

10 11 |  12 |  13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34